Ecuador Medical Device Imports 2026: China-Ecuador Free Trade Agreement and Tariff Reductions

1. Key takeaways

The Free Trade Agreement between China and Ecuador was signed on 2023-05-11 and entered into force on 2024-05-01. It is the 20th free trade agreement concluded by China and the first free trade agreement signed by Ecuador with an Asian country. The two parties progressively eliminate tariffs on approximately 90% of tariff lines, of which roughly 60% fall to zero immediately on the day of entry into force. Proper use of the rules of origin can materially reduce the ad valorem duty, but it does not affect IVA, FODINFA or ISD.

2. Legal basis

Verification note: the signature date and entry into force date of the agreement have been confirmed against public information of the Ministry of Commerce of China. The tariff reduction timetable for each specific tariff line must be checked in the corresponding tariff code of the tariff concession schedule; the pace of liberalization differs across lines (immediate zero, staged reduction, or exception). Announcements made in 2024 by the trade authorities of both parties remain the primary reference for confirming the effective date and the scope of the first stage of liberalization.

3. Expert insights

Insight 1: The FTA affects only the first layer of the four-layer tax structure. The China-Ecuador FTA reduces the ad valorem customs duty; IVA at 15%, FODINFA at 0.5% and ISD at 5% are all unaffected by the agreement. Reading the FTA as a broad reduction of import cost will overstate the benefit, because the majority of the fiscal layers remain exactly as before. A simple worked comparison makes the point: on a shipment where the duty is fully eliminated, the IVA base still includes the CIF value in full, and the FODINFA and ISD charges are computed exactly as they would be for goods from any other origin.

Insight 2: In the phrase progressive elimination for about 90% of tariff lines, the word progressive is the decisive qualifier. About 60% of lines fall to zero on the day of entry into force, the remaining roughly 30% are reduced in stages under different transition periods, and a small number of lines are excluded entirely. For any given tariff code, the concession schedule must be consulted to establish its specific reduction path.

Insight 3: The rules of origin are a precondition for enjoying the tariff reduction. Products of Chinese origin must obtain a certificate of origin and submit it at customs clearance. Eligibility is determined under the chapter on rules of origin, applying criteria such as wholly obtained status and substantial transformation. Without the certificate at clearance, the importer cannot claim the preferential rate for that shipment, and recovering the difference afterwards is generally not a practical route, so the document must be treated as a shipping document of the same rank as the invoice and the transport document.

Insight 4: Assembled products require particular attention to the substantial transformation standard. Where the key components of a product come from third countries, the product may fail the origin test. Origin planning should be completed at the supply chain design stage, not as a remedy at the time of shipment. For device categories in which boards, sensors or sterile barrier components are commonly sourced across borders, the bill of materials should be reviewed against the product-specific rule in the agreement before any preferential treatment is promised to the customer.

Insight 5: The FTA and the simplified registration channel are two independent acceleration routes. The simplified route (Articles 31 to 33) recognizes registration evidence from highly regulated authorities, regardless of the country of origin of the product. Chinese origin is no obstacle to the simplified channel, but neither can it substitute for the evidence requirements of that channel. The two tools answer different questions, one about the tariff paid at the border and the other about the registration evidence accepted by ARCSA, and a plan that maximizes one does nothing automatic for the other.

4. Practical recommendations

1. Query the tariff concession schedule by specific tariff code, and confirm the reduction path and the currently applicable rate, rather than relying on a broad practical estimate such as 90% to zero.
2. Complete the origin eligibility assessment at the supply chain design stage, in particular for products containing third-country components.
3. Establish a process for applying for and retaining certificates of origin, since they must accompany the shipment at clearance.
4. Enter only the duty reduction from the FTA into the quotation model, and continue to charge IVA, FODINFA and ISD in full.
5. Evaluate the FTA and the simplified registration channel as two separate tools, and keep their effects distinct in planning.

5. Verification checklist

• □ The tariff concession schedule has been queried by specific tariff code and the applicable rate confirmed
• □ The origin eligibility assessment of the product has been completed
• □ A process for applying for and retaining certificates of origin has been established
• □ The quotation model correctly separates the FTA reduction from the other three tax layers
• □ It has been confirmed that origin does not affect the applicability of the simplified registration channel
• □ The substantial transformation test has been completed for products with third-country components

Regulatory information verified as of October 29, 2026

GRZAN service note

GRZAN provides regulatory support in this country for medical device manufacturers, importers and authorized representatives, covering registration pathway planning, FTA tariff benefit and origin analysis, licensing structure design, official fee and timeline estimation, technical dossier preparation, and post-market compliance management. Manufacturers and importers from the Chinese mainland evaluating the China-Ecuador FTA for device shipments may contact GRZAN at info@grzanglobal.com for a tailored solution.